Comparison of the Thrombotest with the One-Stage Prothrombin Time
- 28 December 1961
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 265 (26) , 1286-1289
- https://doi.org/10.1056/nejm196112282652604
Abstract
THE one-stage prothrombin time was developed to serve as a diagnostic tool and was initially employed to study the bleeding state that was frequently encountered postoperatively in the jaundiced patient.1 A sequence to this investigation was the finding that the prothrombin time was increased in vitamin K deficiency and in poisoning from spoiled sweet-clover hay.2 As a result of these observations, as well as because of the simplicity of the procedure, the test was immediately employed to control dosage when bishydroxycoumarin was introduced into therapy.3 , 4 Before this new use the test had been perfected by the preparation of a thromboplastin . . .Keywords
This publication has 14 references indexed in Scilit:
- A New Test for Anticoagulant TherapyJAMA, 1961
- Thrombotest versus One-Stage Prothrombin-Time DeterminationNew England Journal of Medicine, 1961
- CONTROL OF ANTICOAGULANT THERAPY A TRIAL OF THROMBOTESTThe Lancet, 1959
- THROMBOTEST A NEW METHOD FOR CONTROLLING ANTICOAGULANT THERAPYThe Lancet, 1959
- The Hereditary Haemorrhagic Diseases: Their Classification and DiagnosisBMJ, 1959
- Relation of Hemorrhage and Thrombosis to Prothrombin during Treatment with Coumarin-Type AnticoagulantsNew England Journal of Medicine, 1958
- STUDIES ON THE HEMORRHAGIC AGENT 3,3'-METHYLENEBIS (4-HYDROXYCOUMARIN).The Lancet Healthy Longevity, 1941
- THE NATURE OF THE BLEEDING IN JAUNDICEJAMA, 1938
- THE COAGULATION DEFECT IN SWEET CLOVER DISEASE AND IN THE HEMORRHAGIC CHICK DISEASE OF DIETARY ORIGINAmerican Journal of Physiology-Legacy Content, 1937
- A STUDY OF THE COAGULATION DEFECT IN HEMOPHILIA AND IN JAUNDICE.*The Lancet Healthy Longevity, 1935